TITLE

Fms-like Tyrosine Kinase (FLT) 3 and FLT3 Internal Tandem Duplication in Different Types of Adult Leukemia: Analysis of 147 Patients

PUB. DATE
October 2008
SOURCE
Croatian Medical Journal;2008, Vol. 49 Issue 5, p650
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
35116118

 

Related Articles

  • Should the Detection of a Mutation of Fms-like Tyrosine Kinase 3 (FLT3) Influence the Management of a Young Adult with Acute Myeloid Leukemia? Mead, Adam // Current Medical Literature: Leukemia & Lymphoma;2006, Vol. 14 Issue 4, p85 

    The article discusses the influence of the detection of a mutation of Fms-like Tyrosine Kinase 3 (FLT3) on the management of a young adult with acute myeloid leukemia (AML). It describes FLT3 as a receptor tyrosine kinase expressed on the surface of hematopoietic stem cells and on blast cells....

  • FLT3 Mutations at Diagnosis and Relapse in Acute Myeloid Leukemia. McCormick, Stanley R.; McCormick, Matthew J.; Grutkoski, Patricia S.; Ducker, Gregory S.; Banerji, Nilanjana; Higgins, Rodney R.; Mendiola, John R.; Reinartz, John J. // Archives of Pathology & Laboratory Medicine;Aug2010, Vol. 134 Issue 8, p1143 

    Context--Acquired mutations in the fms-like tyrosine kinase 3 gene (FLT3) adversely impact relapse risk after chemotherapy in patients with acute myeloid leukemia (AML). The FLT3 mutation status may differ at diagnosis and relapse, suggesting a potential role in chemoresistance, yet few reports...

  • The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients. Ponziani, V.; Gianfaldoni, G.; Mannelli, F.; Leoni, F.; Ciolli, S.; Guglielmelli, P.; Antonioli, E.; Longo, G.; Bosi, A.; Vannucchi, A. M. // Leukemia (08876924);Nov2006, Vol. 20 Issue 11, p2074 

    The article analyzes the correlation between the size of duplicated sequences of nucleotides and the outcome in acute myeloid leukemia (AML) patients. The article studies the molecular characteristics of the internal tandem duplication of fms-like tyrosine kinase 3-FLT3 gene (FLT3/ITDs). The...

  • Tandem duplication of the FLT3 gene in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual disease. Nakao, M; Janssen, J W G; Erz, D; Seriu, T; Bartram, C R // Leukemia (08876924);Mar2000, Vol. 14 Issue 3, p522 

    Focuses on the use of fms-like tyrosine kinase 3 (FLT3) gene as marker for detection of minimal residual disease. Features of FLT3 gene; Structure of the gene; Duplication of FLT3 gene in acute lymphoblastic leukemia; Clinical significance of FLT3 in childhood and adult acute myeloblastic...

  • FLT3 regulates β-catenin tyrosine phosphorylation, nuclear localization, and transcriptional activity in acute myeloid leukemia cells. Kajiguchi, T.; Chung, E. J.; Lee, S.; Stine, A.; Kiyoi, H.; Naoe, T.; Levis, M. J.; Neckers, L.; Trepel, J. B. // Leukemia (08876924);Dec2007, Vol. 21 Issue 12, p2476 

    Deregulated accumulation of nuclear β-catenin enhances transcription of β-catenin target genes and promotes malignant transformation. Recently, acute myeloid leukemia (AML) cells with activating mutations of FMS-like tyrosine kinase-3 (FLT3) were reported to display elevated...

  • Sorafenib.  // Reactions Weekly;2/20/2016, Vol. 1589 Issue 1, p184 

    An abstract of the article "Sorafenib combined with non-conventional chemotherapy produces deep remissions in FMS-like tyrosine kinase-3 gene / internal tandem duplication positive (FLT-3 / ITD+) acute myeloid leukemia (AML) patients" by S. Banavali and others is presented.

  • Activating mutations of the fms-like tyrosine kinase-3 internal tandem duplication (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia.  // Current Medical Literature: Leukemia & Lymphoma;2012, Vol. 20 Issue 3, p97 

    The author comments on the paper "Activating mutations of the fms-like tyrosine kinase-3 internal tandem duplication (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia (AML), " by A. Nazha and colleagues. The author notes the study support the theory that FLT3...

  • Incidence of FLT3 and nucleophosmin gene mutations in childhood acute myeloid leukemia: Serbian experience and the review of the literature. Krstovski, Nada; Tosic, Natasa; Janic, Dragana; Dokmanovic, Lidija; Kuzmanovic, Milos; Spasovski, Vesna; Pavlovic, Sonja // Medical Oncology;Sep2010, Vol. 27 Issue 3, p640 

    Mutations in the fms-like tyrosine kinase 3 (FLT3) gene (internal tandem duplication (ITD) and point mutation in the tyrosine kinase domain, FLT3/D835) as well as the nucleophosmin (NPM1) gene are the most common abnormalities in adult acute myeloid leukemia (AML). Their significance in...

  • Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia. Colovic, Natasa; Tosic, Natasa; Aveic, Sanja; Djuric, Marija; Milic, Natasa; Bumbasirevic, Vladimir; Colovic, Milica; Pavlovic, Sonja // Annals of Hematology;Oct2007, Vol. 86 Issue 10, p741 

    Mutations in the fms-like tyrosine kinase 3 (FLT3) gene, such as internal tandem duplication (FLT3/ITD) in the juxtamembrane domain and point mutations in the tyrosine kinase domain, are the most common abnormalities in acute myeloid leukemia (AML). FLT3/ITD and FLT3/D835 mutations were analyzed...

  • Implications of FLT3 Mutations in the Therapy of Acute Myeloid Leukemia. Mattison, Ryan J.; Ostler, Kelly R.; Locke, Frederick L.; Godley, Lucy A. // Reviews on Recent Clinical Trials;May2007, Vol. 2 Issue 2, p135 

    FMS-like tyrosine kinase 3 (FLT3) is a type III receptor tyrosine kinase that is expressed on the surface of hematopoietic stem cells and plays an important role in normal hematopoiesis. FLT3 is mutated in approximately one-third of cases of acute myeloid leukemia (AML) with normal karyotype....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics